8 Apr.

Leading voices on COVID-19 and the path forward

The catalyst to a reimagined future

Thursday, 11:00 a.m.  ET
Event language: English
Register now

Join us as we convene some of the brightest minds in life sciences, health care, and public health in a conversation about coming together to emerge stronger amid COVID-19. Our third and final conversation will focus on how we can use the lessons learned from the COVID-19 pandemic as a catalyst to build a more resilient health care ecosystem and better prepare our nation for the potential public health threats of the future. Please join us for our last dialogue to hear leading thinkers discuss this pivotal time in history.

Meet the speakers

Asif Dhar

Asif Dhar

Industry Leader | Life Sciences and Health Care

Dr. Dhar is Vice Chairman and US Life Sciences and Health Care (LSHC) Industry Leader for Deloitte LLP leading the overall strategic direction for the life sciences and health care practices, including audit, consulting, tax, and advisory services. He is a respected health futurist and sought-after digital disrupter. Asif helps Governments, Life Sciences and Health Care clients reinvent wellness, solve disease, address pandemics and tackle health inequities. He is also Deloitte’s Lead Partner for the Firm’s US Food and Drug Administration (FDA) relationship and responsible for all work Deloitte performs with and for the Agency. His perspectives on real world evidence, regulatory sciences, digital health, and innovation are sought by clients around the world. Asif’s passion for the LSHC industry is evident in all that he does – as a pioneering thought leader who helped establish a framework for the Future of Health, formed ConvergeHEALTH, an award winning life sciences and health care software solution, and helped frame numerous COVID-19 health-oriented reboot and recovery solutions. He advises some of the world’s most innovative companies and Governmental agencies tackling disease and public health.

Dr. Mark McClellan

Director, Duke-Robert J. Margolis, Center for Health Policy, MD Professor of Business, Medicine, and Policy, Duke University

Mark McClellan, MD, PhD, is a Director of Duke-Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. Dr. McClellan is at the center of the nation’s efforts to combat the pandemic and the author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country. He is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. Dr. McClellan is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Arsenal Capital Group, Blackstone Life Sciences, and MITRE.

Dr. Syra Madad

Infectious Disease Epidemiologist and Sr. Director, System Wide Special Pathogens Program NYC Health + Hospitals, NYC Health + Hospitals

Syra Madad, D.H.Sc., M.Sc., MCP is a nationally recognized public health leader and epidemiologist in infectious disease and special pathogen preparedness and response. She is a Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is a Principal Investigator of NYC Health + Hospitals Institute of Diseases and Disaster Management and Health & Safety Lead of the Enhanced Special Investigations Unit of NYC Test & Trace Corp. In addition, Dr. Madad is a Core Faculty in the National Emerging Special Pathogens Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR). She is a Fellow at Harvard University’s Belfer Center for Science and International Affairs, Adjunct Senior Fellow at the Federation of American Scientists and part of their COVID-19 Taskforce, Alumni Fellow at Johns Hopkins Bloomberg School of Public Health, Center for Health Security’s Emerging Leaders in Biosecurity Program and Alumni Senior Fellow in the Federal Bureau of Investigation’s Behavioral Informatics & Technological Enterprise Studies Program.

Thursday, 8 Apr 2021 11:00 a.m. ET
Share Share event on social
Register now